0000784199-23-000058.txt : 20230301
0000784199-23-000058.hdr.sgml : 20230301
20230301184957
ACCESSION NUMBER: 0000784199-23-000058
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230223
FILED AS OF DATE: 20230301
DATE AS OF CHANGE: 20230301
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LEE DAVID ASHLEY
CENTRAL INDEX KEY: 0001112830
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-13165
FILM NUMBER: 23695669
MAIL ADDRESS:
STREET 1: C/O CRYOLIFE INC
STREET 2: 1655 ROBERTS BLVD NW
CITY: KENNESAW
STATE: GA
ZIP: 30144
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ARTIVION, INC.
CENTRAL INDEX KEY: 0000784199
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 592417093
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1655 ROBERTS BOULEVARD N W
CITY: KENNESAW
STATE: GA
ZIP: 30144
BUSINESS PHONE: 7704193355
MAIL ADDRESS:
STREET 1: 1655 ROBERTS BOULEVARD N W
CITY: KENNESAW
STATE: GA
ZIP: 30144
FORMER COMPANY:
FORMER CONFORMED NAME: CRYOLIFE INC
DATE OF NAME CHANGE: 19940526
4
1
wf-form4_167771458039755.xml
FORM 4
X0306
4
2023-02-23
0
0000784199
ARTIVION, INC.
AORT
0001112830
LEE DAVID ASHLEY
ARTIVION, INC.
1655 ROBERTS BLVD, NW
KENNESAW
GA
30144
0
1
0
0
Executive VP, COO & CFO
Common Stock
2023-02-23
4
A
0
4713
0
A
337011
D
Common Stock
2023-02-27
4
S
0
1492
12.938
D
335519
D
Common Stock
2023-02-23
4
A
0
10122
0
A
345641
D
Common Stock
2023-02-27
4
S
0
1602
12.938
D
344039
D
Common Stock
22560
I
*Indirect shares owned by Spouse (5,000), Shares to DAL Trust (17,560)
Represents performance stock units granted on Feb 23, 2022. Hundred percent (100%) were issued on Feb 23, 2023.
These shares were sold upon the vesting of performance stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction.
Represents performance stock units granted on Feb 23, 2022. Fifty percent (50%) were issued on Feb 23, 2023. The remaining shares earned in connection with the Feb 2022 grant will be eligible to vest and be issued as follows: 25% on 02/23/2024, and 25% on 02/23/2025, assuming continued employment on the relevant vesting date.
/s/ David Ashley Lee
2023-02-28